High-throughput RNAi screen for essential genes and drug synergistic combinations in colorectal cancer

Metastatic colorectal cancer is a leading cause of cancer death. However, current therapy options are limited to chemotherapy, with the addition of anti-EGFR antibodies for patients with RAS wild-type tumours. Novel drug targets, or drug combinations that induce a synergistic response, would be of g...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Steven P., Barthorpe, Andrew S., Lightfoot, Howard, Garnett, Mathew J., McDermott, Ultan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Data Descriptor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625556/
https://www.ncbi.nlm.nih.gov/pubmed/28972570
http://dx.doi.org/10.1038/sdata.2017.139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625556/
https://www.ncbi.nlm.nih.gov/pubmed/28972570
http://dx.doi.org/10.1038/sdata.2017.139

Ejemplares similares